Johnston PG - Search Results

1

T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.

Redmond KL, Crawford NT, Farmer H, D'Costa ZC, O'Brien GJ, Buckley NE, Kennedy RD, Johnston PG, Harkin DP, Mullan PB. Redmond KL, et al. Among authors: johnston pg. Oncogene. 2010 Jun 3;29(22):3252-62. doi: 10.1038/onc.2010.84. Epub 2010 Mar 29. Oncogene. 2010. PMID: 20348948

2

The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosis.

Mullan PB, Hosey AM, Buckley NE, Quinn JE, Kennedy RD, Johnston PG, Harkin DP. Mullan PB, et al. Among authors: johnston pg. Oncogene. 2005 Aug 18;24(35):5492-501. doi: 10.1038/sj.onc.1208698. Oncogene. 2005. PMID: 15940267

3

The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.

Buckley NE, Conlon SJ, Jirstrom K, Kay EW, Crawford NT, O'Grady A, Sheehan K, Mc Dade SS, Wang CW, McCance DJ, Johnston PG, Kennedy RD, Harkin DP, Mullan PB. Buckley NE, et al. Among authors: johnston pg. Cancer Res. 2011 Mar 1;71(5):1933-44. doi: 10.1158/0008-5472.CAN-10-2717. Cancer Res. 2011. PMID: 21363924

4

Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.

Hill A, McFarlane S, Mulligan K, Gillespie H, Draffin JE, Trimble A, Ouhtit A, Johnston PG, Harkin DP, McCormick D, Waugh DJ. Hill A, et al. Among authors: johnston pg. Oncogene. 2006 Oct 5;25(45):6079-91. doi: 10.1038/sj.onc.1209628. Epub 2006 May 1. Oncogene. 2006. PMID: 16652145

5

BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.

Mullan PB, Quinn JE, Gilmore PM, McWilliams S, Andrews H, Gervin C, McCabe N, McKenna S, White P, Song YH, Maheswaran S, Liu E, Haber DA, Johnston PG, Harkin DP. Mullan PB, et al. Among authors: johnston pg. Oncogene. 2001 Sep 27;20(43):6123-31. doi: 10.1038/sj.onc.1204712. Oncogene. 2001. PMID: 11593420

6

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, Harkin DP. Quinn JE, et al. Among authors: johnston pg. Cancer Res. 2003 Oct 1;63(19):6221-8. Cancer Res. 2003. PMID: 14559807

7

BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3.

Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP. Gilmore PM, et al. Among authors: johnston pg. Cancer Res. 2004 Jun 15;64(12):4148-54. doi: 10.1158/0008-5472.CAN-03-4080. Cancer Res. 2004. PMID: 15205325

8

The role of BRCA1 in the cellular response to chemotherapy.

Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. Kennedy RD, et al. Among authors: johnston pg. J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68. doi: 10.1093/jnci/djh312. J Natl Cancer Inst. 2004. PMID: 15547178 Review.

9

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. Kennedy RD, et al. Among authors: johnston pg. Cancer Res. 2005 Nov 15;65(22):10265-72. doi: 10.1158/0008-5472.CAN-05-1841. Cancer Res. 2005. PMID: 16288014

10

BRCA1, a potential predictive biomarker in the treatment of breast cancer.

James CR, Quinn JE, Mullan PB, Johnston PG, Harkin DP. James CR, et al. Among authors: johnston pg. Oncologist. 2007 Feb;12(2):142-50. doi: 10.1634/theoncologist.12-2-142. Oncologist. 2007. PMID: 17296808 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters